Literature DB >> 23090853

Dynamic changes of FDG uptake and clearance in normal tissues.

Gang Cheng1, Abass Alavi, Esther Lim, Thomas J Werner, Catherine V Del Bello, Scott R Akers.   

Abstract

PURPOSE: This study aims to evaluate dynamic 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) uptake in normal tissues. PROCEDURES: Thirty male patients underwent FDG positron emission tomography (PET)/computed tomography imaging at 1, 2, and 3 h after tracer injection. Standardized uptake values (SUV) were obtained in regions of interest of normal tissues.
RESULTS: The aorta (blood pool), liver, and spleen FDG activity demonstrated significantly and continuously decreased activity from 1 to 2 and 2 to 3 h, while FDG uptake in the lungs, pancreas, lymph nodes, and skeletal muscle decreased from 1 to 2 h only. In contrast, the left ventricular myocardium demonstrated two patterns of dynamic changes: myocardium with higher FDG uptake (SUVmax ≥ 3.25) on the initial images had more remarkable increased activity on the delayed images, while myocardium with lower FDG uptake (SUVmax < 3.25) on the initial imaging had no increased uptake on delayed imaging. Increased FDG uptake was also observed in the bones on the delayed images. No significant changes of FDG uptake were noted in the parotid gland, thyroid gland, and prostate gland.
CONCLUSIONS: These findings may help nuclear medicine physicians when comparing images performed at different time points, when using FDG uptake in internal reference regions as a relative indicator of FDG uptake in a specific lesion, and when reading a delayed FDG PET imaging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23090853     DOI: 10.1007/s11307-012-0600-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  28 in total

1.  Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.

Authors:  Yen-Kung Chen; Yeh-You Shen; Chia-Hung Kao
Journal:  Clin Nucl Med       Date:  2004-04       Impact factor: 7.794

2.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Authors:  Dominique Delbeke; R Edward Coleman; Milton J Guiberteau; Manuel L Brown; Henry D Royal; Barry A Siegel; David W Townsend; Lincoln L Berland; J Anthony Parker; Karl Hubner; Michael G Stabin; George Zubal; Marc Kachelriess; Valerie Cronin; Scott Holbrook
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

3.  Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.

Authors:  V Arena; A Skanjeti; R Casoni; A Douroukas; E Pelosi
Journal:  Radiol Med       Date:  2008-07-10       Impact factor: 3.469

4.  Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.

Authors:  R M Wolfort; P W Papillion; R H Turnage; D L Lillien; M R Ramaswamy; G B Zibari
Journal:  Int Surg       Date:  2010 Jan-Mar

5.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.

Authors:  R Hustinx; R J Smith; F Benard; D I Rosenthal; M Machtay; L A Farber; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-10

6.  [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].

Authors:  D Fuster; S Lafuente; X Setoain; I Navales; A Perissinotti; J Pavia; P Paredes; F Lomeña; F Pons
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2011-12-07       Impact factor: 1.359

7.  Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.

Authors:  N Gupta; H Gill; G Graeber; H Bishop; J Hurst; T Stephens
Journal:  Chest       Date:  1998-10       Impact factor: 9.410

8.  Dual-time-point FDG-PET/CT for the detection of hepatic metastases.

Authors:  Albert Dirisamer; Benjamin S Halpern; Wolfgang Schima; Martin Heinisch; Florian Wolf; Mohsen Beheshti; Franz Dirisamer; Michael Weber; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2008-08-16       Impact factor: 3.488

9.  Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.

Authors:  Bennett B Chin; Edward D Green; Timothy G Turkington; Thomas C Hawk; R Edward Coleman
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

10.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

Authors:  V J Lowe; D M DeLong; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

View more
  32 in total

1.  SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.

Authors:  Thomas C Kwee; Gang Cheng; Marnix G E H Lam; Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10       Impact factor: 9.236

2.  Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.

Authors:  Sofie Bæk Christlieb; Casper Nørgaard Strandholdt; Birgitte Brinkmann Olsen; Karen Juul Mylam; Thomas Stauffer Larsen; Anne Lerberg Nielsen; Max Rohde; Oke Gerke; Karen Ege Olsen; Michael Boe Møller; Bjarne Winther Kristensen; Niels Abildgaard; Abass Alavi; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-22       Impact factor: 9.236

3.  Do myocardial PET-MR and PET-CT FDG images provide comparable information?

Authors:  Jorge D Oldan; Shetal N Shah; Richard C Brunken; Frank P DiFilippo; Nancy A Obuchowski; Michael A Bolen
Journal:  J Nucl Cardiol       Date:  2015-06-13       Impact factor: 5.952

4.  Time to move to PET-MR for cardiovascular imaging.

Authors:  Olivier Lairez; Philip M Robson; Zahi A Fayad
Journal:  J Nucl Cardiol       Date:  2015-07-02       Impact factor: 5.952

5.  Clinical Evaluation of PET Image Quality as a Function of Acquisition Time in a New TOF-PET/MRI Compared to TOF-PET/CT--Initial Results.

Authors:  Konstantinos G Zeimpekis; Felipe Barbosa; Martin Hüllner; Edwin ter Voert; Helen Davison; Patrick Veit-Haibach; Gaspar Delso
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

6.  Adjustment of vascular 2-deoxy-2-[18F]fluoro-D-glucose uptake values over time through a modeling approach.

Authors:  Pavlos P Kafouris; Iosif P Koutagiar; Alexandros T Georgakopoulos; Nikoletta K Pianou; Marinos G Metaxas; George M Spyrou; Constantinos D Anagnostopoulos
Journal:  Int J Cardiovasc Imaging       Date:  2019-01-31       Impact factor: 2.357

7.  Dynamic changes of 18F-FDG uptake in normal lung: probing a predictive model analysis.

Authors:  Eric Laffon; Roger Marthan
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

8.  Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinoma.

Authors:  Floris H P van Velden; Ida A Nissen; Femke Jongsma; Linda M Velasquez; Wendy Hayes; Adriaan A Lammertsma; Otto S Hoekstra; Ronald Boellaard
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

9.  Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging.

Authors:  Lucia Leccisotti; Francesco Perna; Mariaelena Lago; Milena Leo; Antonella Stefanelli; Maria L Calcagni; Gemma Pelargonio; Maria L Narducci; Gianluigi Bencardino; Fulvio Bellocci; Alessandro Giordano
Journal:  J Nucl Cardiol       Date:  2014-04-10       Impact factor: 5.952

10.  Ultra staging to unmask the prescribing of adjuvant therapy in cancer patients: the future opportunity to image micrometastases using total-body 18F-FDG PET scanning.

Authors:  Patricia M Price; Ramsey D Badawi; Simon R Cherry; Terry Jones
Journal:  J Nucl Med       Date:  2014-03-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.